Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali
- PMID: 12721894
- DOI: 10.1086/368025
Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali
Abstract
There are an estimated 234,000 cases of measles and 13,851 measles-related deaths per year in Mali. In 1998 and 1999, 548,309 children aged 9-59 months were vaccinated against measles during mass campaigns in urban centers across Mali. After the first campaign, measles incidence decreased by 95% in districts encompassing vaccinated urban centers and by 41% in nonvaccinated districts. There was no shift in the proportion of cases by age group in vaccinated centers. Measles in vaccinated districts after the campaign was likely related to persistent transmission in age groups not targeted for vaccination and among children living in nonvaccinated districts. The second campaign (1999) did not change the incidence of measles in vaccinated compared with nonvaccinated centers. Urban mass measles vaccination probably did not affect overall measles transmission in Mali. Mass vaccination of all children in Mali, targeting a larger age group, will be necessary to reach measles control objectives.
Similar articles
-
Failure of targeted urban supplemental measles vaccination campaigns (1997-1999) to prevent measles epidemics in Mozambique (1998-2001).J Infect Dis. 2003 May 15;187 Suppl 1:S51-7. doi: 10.1086/368058. J Infect Dis. 2003. PMID: 12721891
-
Impact of mass measles campaigns among children less than 5 years old in Uganda.J Infect Dis. 2003 May 15;187 Suppl 1:S63-8. doi: 10.1086/368026. J Infect Dis. 2003. PMID: 12721893
-
Measles incidence before and after mass vaccination campaigns in Burkina Faso.J Infect Dis. 2003 May 15;187 Suppl 1:S80-5. doi: 10.1086/368043. J Infect Dis. 2003. PMID: 12721896
-
Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys.Vaccine. 2008 Sep 2;26(37):4769-74. doi: 10.1016/j.vaccine.2008.07.005. Epub 2008 Jul 21. Vaccine. 2008. PMID: 18644417 Review.
-
Population immunity to measles in the United States, 1999.J Infect Dis. 2004 May 1;189 Suppl 1:S91-7. doi: 10.1086/377713. J Infect Dis. 2004. PMID: 15106096 Review.
Cited by
-
Synthesis of Evidence to Characterize National Measles and Rubella Exposure and Immunization Histories.Risk Anal. 2016 Jul;36(7):1427-58. doi: 10.1111/risa.12454. Epub 2015 Aug 6. Risk Anal. 2016. PMID: 26249328 Free PMC article.
-
Measles susceptibility in maternal-infant dyads-Bamako, Mali.Vaccine. 2022 Feb 23;40(9):1316-1322. doi: 10.1016/j.vaccine.2022.01.012. Epub 2022 Jan 31. Vaccine. 2022. PMID: 35101263 Free PMC article.
-
Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.J Virol. 2005 Aug;79(15):9854-61. doi: 10.1128/JVI.79.15.9854-9861.2005. J Virol. 2005. PMID: 16014946 Free PMC article.
-
Evaluation of a mass measles vaccination campaign among school children aged 7-14 years old in Denizli, Turkey.Indian J Pediatr. 2010 Aug;77(8):879-83. doi: 10.1007/s12098-010-0124-z. Epub 2010 Sep 3. Indian J Pediatr. 2010. PMID: 20814843
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical